Frank Klont

590 total citations
27 papers, 244 citations indexed

About

Frank Klont is a scholar working on Molecular Biology, Spectroscopy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Frank Klont has authored 27 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Spectroscopy and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Frank Klont's work include Metabolomics and Mass Spectrometry Studies (9 papers), Mass Spectrometry Techniques and Applications (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Frank Klont is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), Mass Spectrometry Techniques and Applications (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Frank Klont collaborates with scholars based in Netherlands, Switzerland and United States. Frank Klont's co-authors include Rainer Bischoff, Péter Horvatovich, Gérard Hopfgartner, Nick H.T. ten Hacken, Sara Ongay, Nico C. van de Merbel, György B. Halmos, Justina C. Wolters, R. F. Bonner and Stephan J. L. Bakker and has published in prestigious journals such as Analytical Chemistry, Journal of Clinical Epidemiology and Analytica Chimica Acta.

In The Last Decade

Frank Klont

25 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Klont Netherlands 10 135 81 35 22 20 27 244
Linda Salzmann Germany 4 90 0.7× 43 0.5× 29 0.8× 14 0.6× 16 0.8× 11 239
Barry Jones United States 8 186 1.4× 101 1.2× 17 0.5× 11 0.5× 20 1.0× 11 318
Melissa Standley United States 10 131 1.0× 68 0.8× 21 0.6× 20 0.9× 37 1.9× 17 324
Serguei Ilchenko United States 12 126 0.9× 69 0.9× 99 2.8× 14 0.6× 27 1.4× 20 343
Jonathan Kehler United States 13 167 1.2× 118 1.5× 21 0.6× 11 0.5× 14 0.7× 17 385
J. Grace van der Gugten Canada 14 98 0.7× 94 1.2× 166 4.7× 24 1.1× 11 0.6× 23 403
Stefanie Wernisch United States 11 268 2.0× 190 2.3× 32 0.9× 19 0.9× 40 2.0× 13 490
Charlotte Joly France 11 145 1.1× 24 0.3× 47 1.3× 21 1.0× 7 0.3× 29 390
Shanshan Ji Singapore 10 199 1.5× 31 0.4× 22 0.6× 12 0.5× 9 0.5× 21 319
Renata Wawrzyniak Poland 10 211 1.6× 67 0.8× 11 0.3× 12 0.5× 10 0.5× 22 289

Countries citing papers authored by Frank Klont

Since Specialization
Citations

This map shows the geographic impact of Frank Klont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Klont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Klont more than expected).

Fields of papers citing papers by Frank Klont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Klont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Klont. The network helps show where Frank Klont may publish in the future.

Co-authorship network of co-authors of Frank Klont

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Klont. A scholar is included among the top collaborators of Frank Klont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Klont. Frank Klont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kremer, Daan, Tim J. Knobbe, Gérard Hopfgartner, et al.. (2025). Dose, Kidney Function, and a Drug–Excipient Interaction Impair Mycophenolate Mofetil Prodrug Activation in Kidney Transplant Recipients. European Journal of Drug Metabolism and Pharmacokinetics. 50(4). 341–352.
2.
Sand, Jannie Marie Bülow, Theo Borghuis, Diana Julie Leeming, et al.. (2025). The Calprotectin Fragment, CPa9-HNE, Is a Plasma Biomarker of Mild Chronic Obstructive Pulmonary Disease. Cells. 14(15). 1155–1155.
3.
Blokzijl, Hans, et al.. (2025). Pharmacometabolomics Enables Real-World Drug Metabolism Sciences. Metabolites. 15(1). 39–39. 1 indexed citations
5.
Klont, Frank, Daan Kremer, Tim J. Knobbe, et al.. (2022). Assessing the Potential of Untargeted SWATH Mass Spectrometry-Based Metabolomics to Differentiate Closely Related Exposures in Observational Studies. Metabolites. 12(10). 942–942. 4 indexed citations
6.
Klont, Frank, Sok Cin Tye, Daan Kremer, et al.. (2022). Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients. Nephrology Dialysis Transplantation. 37(7). 1375–1383. 5 indexed citations
7.
Klont, Frank, S. Stepanović, Daan Kremer, et al.. (2022). Untargeted ‘SWATH’ mass spectrometry-based metabolomics for studying chronic and intermittent exposure to xenobiotics in cohort studies. Food and Chemical Toxicology. 165. 113188–113188. 7 indexed citations
8.
Klont, Frank, Péter Horvatovich, Russell P. Bowler, et al.. (2022). Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans. Respiratory Research. 23(1). 15–15. 11 indexed citations
9.
Klont, Frank, Daan Kremer, António W. Gomes‐Neto, et al.. (2021). Metabolomics data complemented drug use information in epidemiological databases: pilot study of potential kidney donors. Journal of Clinical Epidemiology. 135. 10–16. 10 indexed citations
10.
Klont, Frank & Gérard Hopfgartner. (2021). Mass spectrometry based approaches and strategies in bioanalysis for qualitative and quantitative analysis of pharmaceutically relevant molecules. Drug Discovery Today Technologies. 40. 64–68. 6 indexed citations
12.
Klont, Frank, Lyanne M. Kieneker, António W. Gomes‐Neto, et al.. (2020). Female Specific Association of Low Insulin-Like Growth Factor 1 (IGF1) Levels with Increased Risk of Premature Mortality in Renal Transplant Recipients. Journal of Clinical Medicine. 9(2). 293–293. 2 indexed citations
13.
Klont, Frank & Gérard Hopfgartner. (2020). Bioanalytical Research and Training in Academia During the COVID-19 Pandemic. Bioanalysis. 12(17). 1209–1211. 3 indexed citations
15.
Klont, Frank, Simon D. Pouwels, Nico C. van de Merbel, et al.. (2019). Quantification of surfactant protein D (SPD) in human serum by liquid chromatography-mass spectrometry (LC-MS). Talanta. 202. 507–513. 9 indexed citations
16.
Klont, Frank, Péter Horvatovich, Natalia Govorukhina, & Rainer Bischoff. (2019). Pre- and Post-analytical Factors in Biomarker Discovery. Methods in molecular biology. 1959. 1–22. 8 indexed citations
18.
Bronsema, Kees J., et al.. (2018). A quantitative LC-MS/MS method for insulin-like growth factor 1 in human plasma. Clinical Chemistry and Laboratory Medicine (CCLM). 56(11). 1905–1912. 19 indexed citations
20.
Boer, Hink, Renske Altena, Janine Nuver, et al.. (2016). Single-nucleotide polymorphism in the 5-α-reductase gene ( SRD5A2 ) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors. European Journal of Cancer. 54. 104–111. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026